Virpax Pharmaceuticals Inc. Common Stock is a leading biopharmaceutical company focused on developing innovative therapies for pain management. With a strong pipeline of potential drugs and a commitment to patient well-being, Virpax is poised to make a significant impact in the healthcare industry.
